ARCHIVES

Rauscher For Cancer Program

This article is from The Cancer Letter archive.

Vol. 03 No. 20 | May 20, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

NCCS Networker Volume 8 Issue 1, Spring 1994

April 13, 1994

NCI Adds $25 Million to R01, P01 Grant Pool In Fiscal 1990

February 23, 1990

ASCO Objects To Proposed Graduate Medical Education Bill

September 20, 1985

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012